Highlights Adimmune Corporation

Equities

4142

TW0004142005

End-of-day quote Taiwan S.E. Other stock markets 03:30:00 09/05/2024 am IST			5-day change	1st Jan Change
28.25 ^TWD	+0.53%		+3.48%	-14.78%

28/03	Adimmune Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
05/02	An unknown buyer acquire 2.14% stake in Adimmune Corporation from BioEngine Technology Development Inc. for NTD300 million.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Adimmune Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	28/03	CI
An unknown buyer acquire 2.14% stake in Adimmune Corporation from BioEngine Technology Development Inc. for NTD300 million.	05/02	CI
Adimmune Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Adimmune Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14	CI
Adimmune Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Adimmune Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	30/23/30	CI
Clover Bio Signs Exclusive Deal to Distribute Influenza Vaccine in China; Shares Climb 3%	20/23/20	MT
Clover Biopharmaceuticals, Ltd. Enters into Exclusive Agreement to Commercialize Quadrivalent Seasonal Influenza Vaccine in Mainland China	20/23/20	CI
Tranche Update on Adimmune Corporation's Equity Buyback Plan announced on November 11, 2022.	21/22/21	CI
Adimmune Corporation's Equity Buyback announced on November 11, 2022 has closed with the repurchase of 5,000,000 shares, representing 1.17% for TWD 182.07 million.	21/22/21	CI
Adimmune Turns Profitable in January-September	14/22/14	MT
Adimmune Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14	CI
Adimmune Corporation announces an Equity Buyback for 5,000,000 shares.	11/22/11	CI
Adimmune Corporation authorizes a Buyback Plan.	11/22/11	CI
Adimmune Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/22/16	CI
Tranche Update on Adimmune Corporation's Equity Buyback Plan announced on June 9, 2022.	09/22/09	CI
Adimmune Corporation's Equity Buyback announced on June 9, 2022, has closed with 3,000,000 shares, representing 0.7% for TWD 110.56 million.	09/22/09	CI
Adimmune Upbeat on H2 Revenue	27/22/27	MT
Adimmune Corporation announces an Equity Buyback for 3,000,000 shares, representing 0.7% for TWD 1,528.09 million.	09/22/09	CI
Adimmune Corporation authorizes a Buyback Plan.	09/22/09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Adimmune Corporation

Equities

4142

TW0004142005

Highlights

Filters